Goldman Sachs’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-174,771
Closed -$315K 7181
2017
Q1
$315K Buy
174,771
+56,005
+47% +$314K ﹤0.01% 5430
2016
Q4
$907K Sell
118,766
-321,159
-73% -$5.91M ﹤0.01% 4543
2016
Q3
$18.9M Sell
439,925
-213,370
-33% -$9.63M 0.01% 1931
2016
Q2
$33.7M Sell
653,295
-398,900
-38% -$23.9M 0.01% 1386
2016
Q1
$58.4M Sell
1,052,195
-937,433
-47% -$48.5M 0.02% 985
2015
Q4
$108M Buy
1,989,628
+789,765
+66% +$50.4M 0.03% 630
2015
Q3
$96.9M Buy
1,199,863
+740,432
+161% +$76.4M 0.03% 640
2015
Q2
$43.6M Sell
459,431
-569,799
-55% -$39.2M 0.01% 1207
2015
Q1
$51.7M Buy
1,029,230
+186,631
+22% +$7.38M 0.02% 1077
2014
Q4
$31.5M Sell
842,599
-60,519
-7% -$1.91M 0.01% 1485
2014
Q3
$22.5M Buy
+903,118
New +$23.6M 0.01% 1705

Other funds holding ADPT

Goldman Sachs's ADPT Position: Q2 2017 in Review

Goldman Sachs sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 174,771 shares — an estimated $315K sold.

Goldman Sachs first reported a position in ADPT in Q3 2014 and held it in 11 quarters. The position peaked at $108M in Q4 2015. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Goldman Sachs reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Goldman Sachs sold 174,771 Adeptus Health Inc shares in Q2 2017, an estimated $315K.
  • Goldman Sachs first reported a position in Adeptus Health Inc in Q3 2014 and held it in 11 quarters.
  • Goldman Sachs's Adeptus Health Inc position peaked at $108M in Q4 2015.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Goldman Sachs's 13F filing for Q2 2017, filed 14 Aug 2017.